The research presented at ENDO 2018 ran the gamut in terms of breakthroughs in endocrine science. Of particular interest were studies that took a closer look at how offspring could be harmed by endocrine disruptors — specifically BPA and DEHP — while still in the womb. Three studies presented at ENDO 2018 in March,...
Duke University Health System has selected Glytec’s eGlycemic Management System® to elevate the quality and safety of care for patients with diabetes and others who require insulin therapy. With national statistics indicating that one of every three hospitalized patients requires insulin therapy during their stay, administering the right dose at the right time in accordance...
Data on the use of dapagliflozin in diverse patient populations with type 2 and type 1 diabetes (T2D, T1D) at the American Diabetes Association (ADA) 78th Scientific Sessions in Orlando, Fla. reinforce the use of dapagliflozin as a treatment option to help improve glycemic control when used with the DPP-4 inhibitor saxagliptin versus older treatment...
Real-World Study of More than 700,000 People with Type 2 Diabetes (T2D) Shows No Increased Risk of Below-Knee Lower Extremity Amputations with Canagliflozin Compared to Other Diabetes Medications A new real-world analysis of more than 700,000 U.S. T2D patients found no increased risk of below-knee lower extremity (BKLE) amputation with canagliflozin compared to other sodium glucose...
The U.S. Food and Drug Administration (FDA) has approved the use of the MiniMed(TM) 670G system in patients with type 1 diabetes seven years of age and older. This newest system by Medtronic features SmartGuard(TM) technology the Guardian Sensor 3, which work together to automate the delivery of a personalized amount of basal insulin every...
Researchers may have come across a novel treatment target to treat the rare but aggressive cancer adrenocortical carcinoma (ACC), according to a study recently published in Endocrinology. The researchers, led by Wiebke Arlt and Paul A. Foster, both of the University of Birmingham in the United Kingdom, write that the mitochondrial NADPH generator Nicotinamide Nucleotide...
Patients with multiple endocrine neoplasia type 1 (MEN1) suffer from a fear of disease occurrence that is associated with a lower quality of life, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Gerlof D. Valk, MD, PhD, of the University Medical Center Utrecht in the Netherlands,...
Research supports thyroid screenings during early to mid-pregnancy Women with thyroid dysfunction in the first half of pregnancy face an increased risk for gestational diabetes, a form of diabetes that is typically diagnosed during the second trimester, according to a new study published in The Journal of Clinical Endocrinology & Metabolism. Thyroid dysfunction is common...
As much as we know today about the endocrine system and the effects it has on the body, there remains so much that we do not know. Discoveries are made every day, and our understanding of the endocrine system is always growing and changing. Serving patients to the best of an endocrinologist’s abilities means being aware of all the latest developments in endocrine research. This includes the newest and most complete information concerning such endocrinology research topics as new treatments and new methods for disease prevention. Identifying symptoms and making the connections between those symptoms and endocrine disease can lead to greater understanding and ultimately better treatment for patients. More advanced prevention techniques can help patients stave off disease before it can impact their lives. Having the most current information can make a tremendous difference in the quality of life for your patients.
This section features some of the most current and forward-looking articles concerning the latest research in endocrinology. Written by and for endocrinologists, these articles are provided to keep you up to date with the most relevant developments in the field of endocrinology. You can access the information you need about new technology, new treatments and general information to help you serve your patients with better overall care. Our understanding of the endocrine system is always evolving. With Endocrine News, you can ensure that your knowledge of the field won’t be left behind. What’s more, your patients will always have access to the most advanced information out there.
The research presented at ENDO 2018 ran the gamut in terms of breakthroughs in endocrine science. Of particular interest were studies that took a closer look at how offspring could be harmed by endocrine disruptors — specifically BPA and DEHP — while still in the womb. Three studies presented at ENDO 2018 in March,...
